![]() |
產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS10505 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-Pokemon |
克隆性 | |
靶點(diǎn) | 詳見(jiàn)說(shuō)明書(shū) |
適應(yīng)物種 | 詳見(jiàn)說(shuō)明書(shū) |
形態(tài) | 詳見(jiàn)說(shuō)明書(shū) |
宿主 | 詳見(jiàn)說(shuō)明書(shū) |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書(shū) |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human Pokemon C-terminus |
產(chǎn)品訂購(gòu)信息:
英文名稱(chēng) Anti-Pokemon
中文名稱(chēng) 撲克蒙蛋白抗體費(fèi)用
別 名 Factor binding IST protein 1; Factor that binds to inducer of short transcripts protein 1; FBI-1; FBI1; -1 1st-binding protein 1; Leukemia/lymphoma related factor; LRF; Pokemon; TIP21; TTF-I interacting peptide 21; ZBTB7; ZBTB7A; Zinc finger and BTB domain-containing protein 7A; ZBT7A_HUMAN.
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類(lèi)型 polyclonal
交叉反應(yīng) Human, Mouse, Rat
產(chǎn)品類(lèi)型 一抗
研究領(lǐng)域 免疫學(xué) 微生物學(xué) 轉(zhuǎn)錄調(diào)節(jié)因子 細(xì)菌及
蛋白分子量 predicted molecular weight: 63kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Pokemon C-terminus
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
撲克蒙蛋白抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Pokemon, the POK erythroid myeloid ontogenic factor, not only regulates the expression of many genes, but also plays an important role in cell tumorigenesis. To investigate the molecular mechanism regulating expression of the Pokemon gene in humans, its 5'-upstream region was cloned and analyzed. Transient analysis revealed that the Pokemon promoter is constitutive. Deletion analysis and a DNA decoy assay indicated that the NEG-U and NEG-D elements were involved in negative regulation of the Pokemon promoter, whereas the POS-D element was mainly responsible for its strong activity. Electrophoretic mobility shift assays suggested that the NEG-U, NEG-D and POS-D elements were specifically bound by the nuclear extract from A549 cells in vitro. Mutation analysis demonstrated that cooperation of the NEG-U and NEG-D elements led to negative regulation of the Pokemon promoter. Moreover, the NEG-U and NEG-D elements needed to be an appropriate distance apart in the Pokemon promoter in order to cooperate. Taken together, our results elucidate the mechanism underlying the regulation of Pokemon gene transcription, and also define a novel regulatory sequence that may be used to decrease expression of the Pokemon gene in cancer gene therapy.
Function : Plays a key role in the instruction of early lymphoid progenitors to develop into B lineage by repressing T-cell instructive Notch signals (By similarity). Specifically represses the transcription of the CDKN2A gene. Efficiently abrogates E2F1-dependent CDKN2A transactivation/de-repression. Binds to the consensus sequence 5'-[GA][CA]GACCCCCCCCC-3'.
Subunit : Interacts with BCL6.
Subcellular Location : Nucleus.
Similarity : Contains 1 BTB (POZ) domain.
Contains 4 C2H2-type zinc fingers.
Database links : UniProtKB/Swiss-Prot: O95365.1
Pokemon(7APOK Erythroid Myeloid Ontogenic factor)能夠控制將正常細(xì)胞變成癌細(xì)胞所需的途徑,Pokemon蛋白是轉(zhuǎn)錄因子蛋白家族的一員,并且在人類(lèi)中發(fā)生了突變。另外Pokemon蛋白作為轉(zhuǎn)錄因子參與一些細(xì)胞基因轉(zhuǎn)錄的調(diào)節(jié),并在細(xì)胞分化過(guò)程中發(fā)揮著關(guān)鍵、多效性的功能。近來(lái)發(fā)現(xiàn),Poke-mon在致癌轉(zhuǎn)化過(guò)程中發(fā)揮著至關(guān)重要的功能,并與的發(fā)生密切相關(guān)。
這種蛋白很可能在實(shí)質(zhì)中處于重要地位,還有學(xué)者認(rèn)為:Pokemon在一定類(lèi)型的B細(xì)胞和T細(xì)胞中水平非常高,并發(fā)現(xiàn)具有高水平Pokemon蛋白表達(dá)對(duì)惡性程度改變更大。
主要定位于細(xì)胞核。
撲克蒙”蛋白又稱(chēng)“波克曼”蛋白。
ANA(Human anti-nucleolus antibody) ELISA Kit 人抗核仁抗體Multi-class antibodies規(guī)格: 48T
Anti-IL-12 (human) 白介素12抗體(人)Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh MAD2 有絲分裂阻滯缺陷蛋白2抗體 規(guī)格 0.2ml
15-LO/LOX(Human 15-lipoxygenase) ELISA Kit 人15脂加氧酶 96T
RTF1 英文名稱(chēng): 組織相容性復(fù)合物RTF1抗體 0.2ml
CCR10 英文名稱(chēng): 細(xì)胞表面趨化因子受體10抗體 0.1ml
Anti-IL-12 (human) 白介素12抗體(人)Multi-class antibodies規(guī)格: 0.2ml
Visfatin-1 (PBEF1)(NT) hu、 mo、 rat、MK 內(nèi)脂素/內(nèi)臟脂肪素(人、大、小鼠、猴同源:N端多肽)、內(nèi)臟脂肪素、前B細(xì)胞克隆增強(qiáng)因子、內(nèi)肥素、腹脂素Multi-class antibodies規(guī)格: 0.5mg
Anti-CD55/DAF 衰變加速因子CD55抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh P2Y2 嘌呤ATP受體抗體 規(guī)格 0.2ml
IL1R1 Kit Rat 大鼠 IL-1R1 / CD121a ELISA配對(duì)抗體 ELISA
TAGLN3 英文名稱(chēng): 神經(jīng)元蛋白22抗體 0.2ml
C20orf96 英文名稱(chēng): 20號(hào)染色體開(kāi)放閱讀框96抗體 0.2ml
Anti-CD55/DAF 衰變加速因子CD55抗體Multi-class antibodies規(guī)格: 0.2ml
Anti-IFN- Gamma/FITC 熒光素標(biāo)記干擾素-γ抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-HSP-90 Beta /HRP 辣根過(guò)氧化物酶標(biāo)記熱休克蛋白90β抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh ARP4 肝生成素相關(guān)蛋白抗體 規(guī)格 0.1ml
Donkey Anti-human IgG/Alexa Fluor 647 Alexa Fluor 647標(biāo)記的驢抗人IgG 0.1ml
GBA2 英文名稱(chēng): β葡萄糖苷酶2抗體 0.2ml
Rhesus antibody Rh Rabbit Anti-Monkey IgG/APC APC標(biāo)記的兔抗猴IgG 規(guī)格 0.1ml
Anti-HSP-90 Beta /HRP 辣根過(guò)氧化物酶標(biāo)記熱休克蛋白90β抗體IgGMulti-class antibodies規(guī)格: 0.2ml
大鼠肌酸激酶同工酶MB(CK-MB)ELISA試劑盒 ,英文名: CK-MB ELISA Kit
The total compleme of guinea pig serum (CH50) ELISA Kit 豚鼠血清總補(bǔ)體(CH50)ELISA試劑盒
對(duì)蝦毒(WSSV)核酸檢測(cè)試劑盒(-PCR法) 48T
CLIAKitforMPF(Humanmaturationpromotingfactor)ELISAKit人成熟促進(jìn)因子規(guī)格:48T/96T
體液輔酶Q含量比色法定量檢測(cè)試劑盒20次
ELISAKitAP12人apelin12規(guī)格:48T/96T
大鼠β2糖蛋白1抗體IgA/G/M(β2-GP1 IgA/G/M)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝
人磷酸酶PP2A癌性抑制物(CIP2A)免疫試劑盒 Human cancerous inhibitor of PP2A,CIP2A ELISA Kit
PorcineCoisolELISAKit豬皮質(zhì)醇(Coisol)ELISA試劑盒規(guī)格:96T/48T
通用型苜?;ㄈ~病病毒(AlfalfaMosaicVirus;AMV)試劑盒20次
humanS100calciumbindingproteinA8/calgranulinA,S100A8ELISA試劑盒人S100鈣結(jié)合蛋白A8/鈣粒蛋白A(S100A8)ELISA試劑盒規(guī)格:96T/48T
HumanulaEsiol,uE3ELISAKit人超敏游離雌三醇(uE3)ELISA試劑盒規(guī)格:96T/48T
撲克蒙蛋白抗體費(fèi)用 大鼠白介素6(IL-6)ELISA試劑盒 ,英文名: IL-6 ELISA Kit
Mouse ierleukin 1 beta (IL-1 beta) ELISA Kit 小鼠白介素1β (IL-1β)ELISA試劑盒
ELISA 小鼠組胺(mouse HIS) 48T/96T 進(jìn)口分裝
CLIAKitforINSELISAKit大鼠規(guī)格:48T/96T
通用型副傷寒沙門(mén)氏菌A(SalmonellaParatyphiA)定性試劑盒20次
ELISAKitApo-E大鼠載脂蛋白E規(guī)格:48T/96T
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn):
1. 撲克蒙蛋白抗體費(fèi)用 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件;
3.用NHSB量過(guò)量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活;
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等;
5.當(dāng)游離ε-氨基(賴(lài)氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性;
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合;
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用;
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定:
1)撲克蒙蛋白抗體費(fèi)用 抗體的效價(jià)鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。
2)抗體的特異性鑒定:抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力??贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3)抗體親和力:是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol??贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。